MGX (Metagenomi) Float Percentage Of Total Shares Outstanding : 72.29% (As of Dec. 13, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Metagenomi's float shares is 27.05 Mil. Metagenomi's total shares outstanding is 37.42 Mil. Metagenomi's float percentage of total shares outstanding is 72.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Metagenomi's Insider Ownership is 10.89%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Metagenomi's Institutional Ownership is 29.76%.

Metagenomi Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Metagenomi's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	27.05	/	37.42
	=	72.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, Emeryville, CA, USA, 94608

Website

https://www.metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).